Defensins and complement systems from the perspective of skin immunity and autoimmunity

Clinics in Dermatology

Volumn 19, Issue 5, 2001, Pages 563-572

  Bos, Jan D ^a   Pasch, Marcel C ^a   Asghar, Syed S ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CLUSTERIN; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT RECEPTOR; DECAY ACCELERATING FACTOR; DEFENSIN; DESMOGLEIN; MEMBRANE COFACTOR PROTEIN; PLASMINOGEN; REGULATOR PROTEIN; THROMBOPLASTIN;

AUTOIMMUNE DISEASE; BULLOUS SKIN DISEASE; CELL SURFACE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; ENDOTHELIUM CELL; HUMAN; IMMUNE SYSTEM; KERATINOCYTE; LANGERHANS CELL; MAST CELL; MELANOCYTE; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCLERODERMA; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; DEFENSINS; HUMANS; IMMUNITY; RECEPTORS, COMPLEMENT; SENSITIVITY AND SPECIFICITY; SKIN DISEASES, VESICULOBULLOUS; SKIN PHYSIOLOGY;

EID: 0034815721     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(00)00174-7     Document Type: Review

References (58)

1. The skin immune system (SIS); Its cellular constituents and their interactions
2. Lymphocyte traffic, T-cell malignancies and the skin
3. Skin-associated lymphoid tissues (SALT); Origins and functions
4. The skin immune system (SIS); Distribution and immunophenotype of lymphocyte subpopulations in normal human skin
5. The skin immune system; Progress in cutaneous biology
6. Immune response in mycobacterioses related to dermatoses
7. Perivascular dendritic macrophages as immunobiological constituents of the human dermal perivascular unit
8. Defensins and host defense
9. Phylogenetic perspectives in innate immunity
10. C3d of complement as a molecular adjuvant; Bridging innate and acquired immunity
11. Function of CD23 in the response of human B cells to antigen
12. A new pair of surface molecules involved in human IgE regulation
13. Membrane regulators of complement activation and their aberrant expression in disease
14. Complement as a promiscuous signal transduction device
15. Regulation of the function of the first component of complement by human C1q receptor
16. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21)
17. Complement in physiopathology of skin
18. Control of the complement system
19. Complement and complement regulatory molecules
20. C1 inhibitor deficiency; Molecular and immunologic basis of hereditary and acquired angioedema
21. Complement factor H and related proteins; An expanding family of complement-regulatory proteins
22. The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system
23. Genetics and deficiencies of the soluble regulatory proteins of the complement system
24. Structure and biological role of vitronectin
25. Clusterin; The intriguing guises of a widely expressed glycoprotein
26. CDNA cloning and primary structure analysis of C1qRp, the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro
27. The C1q and collectin binding site with C1q receptor (cell surface reticulin)
28. Synthesis of complement components C3 and factor B in human keratinocytes is differentially regulated by cytokines
29. Transforming growth factor-beta isoforms regulate the surface expression of membrane cofactor protein (CD46) and CD59 on human keratinocytes
30. Systemic comparison of antibody-mediated mechanisms of keratinocyte lysis in vitro
31. Expression and localization of proteins of the complement system in human skin
32. Characterization of an Epstein-Barr virus receptor on human epithelial cells
33. CD88 antibodies specifically bind to C5aR on dermal CD117+ and CD14+ cells and react with a desmosomal antigen in human skin
34. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells
35. Relative contributions of decay accelerating factor (DAF), membrane cofactor protein (MCP) and CD59 in the protection of melanocytes from homologous complement
36. Functional expression and modulation of C5a receptor (CD88) on skin dendritic cells. Chemotactic effect of C5a on skin dendritic cells
37. Human normal-resting epidermal Langerhans cells do express the type 3 complement receptor
38. Extrahepatic complement biosynthesis-Where, when and why
39. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway
40. Human leukaemic (HMC-1) and normal skin mast cells express beta 2-integrins; Characterization of beta 2-integrins and ICAM-1 on HMC-1 cells
41. Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies
42. The role of complement-derived mediators in inflammatory skin diseases
43. Mechanisms of acantholysis in pemphigus foliaceus
44. Preferential activation of the complement system in the lower epidermis of patients with pemphigus vulgaris
45. Complement fixation by pemphigus antibody II. Complement enhanced detachment of epidermal cells
46. Pemphigus antibodies mediate the development of an inflammatory change in the epidermis. A possible mechanism underlying the feature of eosinophilic spongiosis
47. A major role for neutrophils in experimental bullous pemphigoid
48. Experimental bullous pemphigoid in guinea pigs; The role of pemphigoid antibodies, complement, and migrating cells
49. Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes
50. Studies on complement deposits in epidermolysis bullosa acquisita and bullous pemphigoid
51. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes; Demonstration by leukocytic attachment and organ culture methods
52. Herpes gestationis. Immunopathology and characterization of the HG factor
53. Is antiendothelial cell antibody the murder weapon in systemic sclerosis?
54. Morphoea lesions are associated with aberrant expression of membrane cofactor protein and decay accelerating factor in vascular endothelium
55. Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis
56. The skin immune system; Lupus erythematosus as a paradigm